Ad-Rts-Hil-12, Veledimex, Cemiplimab-Rwlc
Glioblastoma
Phase II
Terminated
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
Jun 28, 2019
―
Ad-Rts-Hil-12, Veledimex
Glioblastoma
Phase I
Completed
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Aug 29, 2018
―
Nivolumab, Ad-Rts-Hil-12, Veledimex
Glioblastoma
Phase I
Completed
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
Jul 05, 2018
―
Ad-Rts-Hil-12, Oral Veledimex - Arm 1, Oral Veledimex - Arm 2
Diffuse Intrinsic Pontine Glioma, Pediatric Brain Tumor
Phase I/II
Terminated
A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG
Oct 16, 2017
―
Ad-Rts-Hil-12, Veledimex
Metastatic Breast Cancer
Phase I/II
Terminated
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer
Apr 06, 2015
―
Ad-Rts-Hil-12, Veledimex
Glioblastoma Multiforme, Anaplastic Oligoastrocytoma
Phase I
Completed
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
Dec 16, 2013
―
Ad-Rts-Hil-12 And Veledimex, Palifosfamide
Breast Cancer Nos Metastatic Recurrent
Phase II
Terminated
Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.
Aug 29, 2012
―
Carboplatin, Etoposide, Palifosfamide-Tris
Extensive-Stage Small Cell Lung Cancer
Phase III
Terminated
Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)
Mar 12, 2012
―
Doxorubicin In Combination With Palifosfamide-Tris
Soft Tissue Sarcoma
Phase III
Terminated
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma
Jul 21, 2010
―
Indibulin
Metastatic Breast Cancer
Phase I
Terminated
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Apr 08, 2010
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alaunos Therapeutics (WEK0) have in its pipeline
WEK0 is currently developing the following drugs: Ad-Rts-Hil-12, Veledimex, Cemiplimab-Rwlc, Ad-Rts-Hil-12, Veledimex, Nivolumab, Ad-Rts-Hil-12, Veledimex. These drug candidates are in various stages of clinical development as the company works toward FDA approval.